AACR Virtual Journal Club:
Molecular Cancer Therapeutics With Dr. Edward B. Reilly
Moderated by: Danielle Large, PhD
Molecular Cancer Therapeutics
This Webinar features Edward B. Reilly, discussing his article published in Molecular Cancer Therapeutics: "ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies." Dr. Reilly discusses the development and preclinical evaluation of novel bispecific T cell engager, ABBV-184.
Stay tuned for the Q&A session at the end of the recording.
About the Featured Speaker:
Edward B. Reilly, PhD, is a Distinguished Research Fellow in the Oncology Discovery Research group within AbbVie. He leads several late-stage discovery programs and has advanced multiple assets to clinical development.